EMA/PE/0000184114 - paediatric investigation plan

duvakitug

Key facts

• Active substance:
  duvakitug
• Therapeutic area:
  Gastrointestinal disorders
• Decision number:
  EMA/PE/0000184114
• PIP number:
  EMA/PE/0000184114
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of Crohn's disease
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  15/05/2025
• Compliance check done:
  Nej

Decision

EMA/PE/0000184114 : EMA decision of 15 May 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for duvakitug

Adopted Reference Number: EMADOC-1700519818-2112659